Significance of extraprostatic extension by Grade Groups 1–3 prostatic carcinoma on needle biopsy
The Prostate · 2023
DOI: 10.1002/pros.24520 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2023. Verfasst von Jianping Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland, United States. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Adenocarcinoma, Carcinoma. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
It is rare for extraprostatic extension (EPE) on biopsy to be seen with Grade Groups (GG) 1–3 (Gleason scores 3 + 3 = 6; 3 + 4 = 7; 4 + 3 = 7) prostatic adenocarcinoma, and there is no data whether this finding should be a contraindication for performing radical prostatectomy (RP).
Methods
Thirty eight cases with GG 1–3 prostatic adenocarcinoma as the highest grade in the case with EPE on biopsy were identified from our consultation files. Highly unfavorable findings at RP were those that if they could have been predicted preoperatively, might have factored into the decision of whether to proceed with surgery. For these purposes, highly unfavorable pathology at RP was defined as either the presence of seminal vesicle invasion or lymph node metastases or GG5 (Gleason score 9–10).
Results
Among 37 patients with clinical follow‐up data, 18 (49%) received radiation and/or hormonal therapy (RT/HT), 13 patients (35%) either underwent ( n = 11) or are planning ( n = 2) RP, and 6 patients (16%) received either ablation therapy or active surveillance. Based on the 11 RP pathology reports, 8 were GG2, one GG3 with tertiary pattern 5, and two GG3. Ten cases were reported to have EPE and six cases had positive margins. Only one had highly unfavorable pathology with pT3bN1 disease. The only difference between the RP and the RT/HT groups in their pretreatment parameters was the mean age of the RP patients was 61 compared with 69 for the RT/HT men ( p = 0.02); the lack of many cases with highly unfavorable pathology at RP cannot be attributable to a selection bias of men with lower volume cancer on biopsy or lower serum prostate‐specific antigen levels choosing RP over RT/HT.
Conclusions
Despite EPE on biopsy, most men do not have highly unfavorable pathology at RP, and this treatment should remain an option in this setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departments of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland, United States.
- Departments of Urology, The Johns Hopkins Hospital, Baltimore, Maryland, United States.
- Departments of Oncology, The Johns Hopkins Hospital, Baltimore, Maryland, United States.
ORCID-Profile: Jonathan Epstein
Zitieren
APA
Zhao, J., & Epstein, J. (2023). Significance of extraprostatic extension by Grade Groups 1–3 prostatic carcinoma on needle biopsy. The Prostate. https://doi.org/10.1002/pros.24520
Vancouver
Zhao J, Epstein J. Significance of extraprostatic extension by Grade Groups 1–3 prostatic carcinoma on needle biopsy. The Prostate. 2023. doi:10.1002/pros.24520
BibTeX
@article{Zhao2023,
author = {Zhao, Jianping and Epstein, Jonathan},
title = {Significance of extraprostatic extension by Grade Groups 1–3 prostatic carcinoma on needle biopsy},
journal = {The Prostate},
year = {2023},
doi = {10.1002/pros.24520}
}
EUVIMED